Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4588.T Stock Summary
Top 10 Correlated ETFs
4588.T
In the News
4588.T Financial details
Company Rating
Neutral
Market Cap
12.54B
Income
-1.94B
Revenue
63.04M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
40
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-6.44
Forward P/E
-
PEG
-1
P/S
45.47
P/B
7.73
P/C
-
P/FCF
-
Quick Ratio
6.19
Current Ratio
6.24
Debt / Equity
0.2
LT Debt / Equity
0.11
-
-
EPS (TTM)
-108.95
EPS next Y
-
EPS next Q
-
EPS this Y
64.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.69%
Revenue last 5Y
-45.44%
Revenue Q/Q
-
EPS Q/Q
55.39%
-
-
-
-
SMA20
15.29%
SMA50
11.5%
SMA100
16.7%
Inst Own
-
Inst Trans
-
ROA
-89%
ROE
-96%
ROC
-1.05%
Gross Margin
23%
Oper. Margin
-620%
Profit Margin
-623%
Payout
-
Shs Outstand
20.19M
Shs Float
18M
-
-
-
-
Target Price
-
52W Range
504.0-780.0
52W High
+0.77%
52W Low
+55.95%
RSI
80.5
Rel Volume
9.38
Avg Volume
260.65K
Volume
2.45M
Perf Week
24.56%
Perf Month
44.75%
Perf Quarter
25.56%
Perf Half Y
35.99%
-
-
-
-
Beta
0.564
-
-
Volatility
60.15%, 52.9%
Prev Close
13.09%
Price
786
Change
25.76%
4588.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 93.68 | 21.83 | 37.98 | 56.34 | 3.54 | |
Net income per share | -65.55 | -145.58 | -95.5 | -66.31 | -108.92 | |
Operating cash flow per share | -17.12 | -101.81 | -102.97 | -99.1 | -75.12 | |
Free cash flow per share | -17.43 | -102 | -103.06 | -99.18 | -75.44 | |
Cash per share | 257.78 | 160.72 | 218.73 | 112.91 | 86.13 | |
Book value per share | 248.18 | 139.2 | 212.47 | 124.62 | 82.83 | |
Tangible book value per share | 248.12 | 139.16 | 212.47 | 124.62 | 82.83 | |
Share holders equity per share | 248.18 | 139.2 | 212.47 | 124.62 | 82.83 | |
Interest debt per share | 38.24 | 36.77 | 30.01 | 22.95 | 16.86 | |
Market cap | 26.76B | 21.63B | 8.93B | 9.13B | 10.09B | |
Enterprise value | 23.95B | 20.09B | 5.98B | 7.81B | 8.87B | |
P/E ratio | -29.33 | -10.32 | -5.53 | -7.95 | -5.21 | |
Price to sales ratio | 20.53 | 68.85 | 13.9 | 9.35 | 160.08 | |
POCF ratio | -112.34 | -14.76 | -5.13 | -5.32 | -7.55 | |
PFCF ratio | -110.35 | -14.74 | -5.12 | -5.31 | -7.52 | |
P/B Ratio | 7.75 | 10.8 | 2.49 | 4.23 | 6.85 | |
PTB ratio | 7.75 | 10.8 | 2.49 | 4.23 | 6.85 | |
EV to sales | 18.37 | 63.94 | 9.31 | 8 | 140.76 | |
Enterprise value over EBITDA | -45.01 | -11.72 | -4.01 | -6.75 | -4.6 | |
EV to operating cash flow | -100.53 | -13.71 | -3.43 | -4.55 | -6.64 | |
EV to free cash flow | -98.75 | -13.68 | -3.43 | -4.55 | -6.61 | |
Earnings yield | -0.03 | -0.1 | -0.18 | -0.13 | -0.19 | |
Free cash flow yield | -0.01 | -0.07 | -0.2 | -0.19 | -0.13 | |
Debt to equity | 0.15 | 0.26 | 0.14 | 0.18 | 0.2 | |
Debt to assets | 0.12 | 0.19 | 0.12 | 0.15 | 0.15 | |
Net debt to EBITDA | 5.29 | 0.9 | 1.98 | 1.14 | 0.63 | |
Current ratio | 7.31 | 6.13 | 9.76 | 8.11 | 5.17 | |
Interest coverage | -129.58 | -401.6 | -348.9 | -305.32 | -535.81 | |
Income quality | 0.26 | 0.7 | 1.08 | 1.5 | 0.69 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | -0.05 | -0.06 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.43 | 3.14 | 1.28 | 0.97 | 21.45 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | -0.01 | 0 | 0 | -0.09 | |
Capex to depreciation | -1.38 | -0.55 | -0.22 | -1.49 | -2.49 | |
Stock based compensation to revenue | 0.1 | 1.2 | 0.33 | 0.06 | 0 | |
Graham number | 605.03 | 675.24 | 675.69 | 431.18 | 450.54 | |
ROIC | -0.13 | -0.66 | -0.36 | -0.47 | -1.08 | |
Return on tangible assets | -0.21 | -0.75 | -0.38 | -0.43 | -0.95 | |
Graham Net | 216.99 | 130.33 | 210.25 | 123 | 58.73 | |
Working capital | 3.3B | 2.13B | 3.77B | 2.29B | 1.58B | |
Tangible asset value | 3.45B | 2B | 3.59B | 2.16B | 1.47B | |
Net current asset value | 2.9B | 1.75B | 3.5B | 2.12B | 1.39B | |
Invested capital | 0.15 | 0.26 | 0.14 | 0.18 | 0.2 | |
Average receivables | 305.48M | 467.52M | 599.44M | 802.17M | 487.23M | |
Average payables | 126.64M | 229.94M | 156.43M | 83.55M | 30.43M | |
Average inventory | 12.99M | 12.69M | 11.06M | 17.95M | 14.8M | |
Days sales outstanding | 130.95 | 542.84 | 415.63 | 326.31 | 589.12 | |
Days payables outstanding | 818.83 | 966.02 | 87.4 | 34.83 | 0 | |
Days of inventory on hand | 48.23 | 48.96 | 9.59 | 13.88 | 60.12 | |
Receivables turnover | 2.79 | 0.67 | 0.88 | 1.12 | 0.62 | |
Payables turnover | 0.45 | 0.38 | 4.18 | 10.48 | 0 | |
Inventory turnover | 7.57 | 7.45 | 38.07 | 26.3 | 6.07 | |
ROE | -0.26 | -1.05 | -0.45 | -0.53 | -1.32 | |
Capex per share | -0.31 | -0.19 | -0.08 | -0.08 | -0.32 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.06 | 2.02 | 1.62 | 0 | 0 | |
Net income per share | -18.11 | -18.69 | -31.47 | -23.02 | 0 | |
Operating cash flow per share | 3.59 | 0 | 0.36 | 0.06 | 0 | |
Free cash flow per share | 3.59 | 0 | 0.36 | 0.06 | 0 | |
Cash per share | 112.93 | 79.8 | 91.26 | 66.27 | 0 | |
Book value per share | 124.64 | 105.99 | 74.52 | 75.3 | 0 | |
Tangible book value per share | 124.64 | 105.99 | 74.52 | 75.3 | 0 | |
Share holders equity per share | 124.64 | 105.99 | 74.52 | 75.3 | 0 | |
Interest debt per share | 22.78 | 20.8 | 25.41 | 18.37 | 0 | |
Market cap | 9.13B | 9.87B | 11.52B | 10.99B | 0 | |
Enterprise value | 7.81B | 8.82B | 10.62B | 10.1B | -1.22B | |
P/E ratio | -7.28 | -7.62 | -5.28 | -6.8 | 0 | |
Price to sales ratio | 47.63 | 282.05 | 410.75 | 0 | 0 | |
POCF ratio | 146.66 | 0 | 1.86K | 10.19K | 0 | |
PFCF ratio | 146.66 | 0 | 1.86K | 10.19K | 0 | |
P/B Ratio | 4.23 | 5.38 | 8.92 | 8.31 | 0 | |
PTB ratio | 4.23 | 5.38 | 8.92 | 8.31 | 0 | |
EV to sales | 40.76 | 252.07 | 378.78 | 0 | 0 | |
Enterprise value over EBITDA | -25.4 | -27.38 | -19.54 | -25.11 | 1.97 | |
EV to operating cash flow | 125.49 | 0 | 1.71K | 9.37K | -379.1 | |
EV to free cash flow | 125.49 | 0 | 1.71K | 9.37K | -379.1 | |
Earnings yield | -0.03 | -0.03 | -0.05 | -0.04 | 0 | |
Free cash flow yield | 0.01 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.18 | 0.2 | 0.34 | 0.24 | 0.2 | |
Debt to assets | 0.15 | 0.16 | 0.24 | 0.18 | 0.15 | |
Net debt to EBITDA | 4.28 | 3.26 | 1.65 | 2.2 | 1.97 | |
Current ratio | 8.11 | 7.54 | 4.85 | 6.24 | 5.17 | |
Interest coverage | -286.61 | -380.79 | -621.39 | -410.87 | -752.06 | |
Income quality | -0.2 | 0 | -0.01 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.84 | 5.12 | 16.33 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.32 | 0 | 0.21 | 0 | 0 | |
Graham number | 225.34 | 211.11 | 229.72 | 197.49 | 0 | |
ROIC | -0.1 | -0.15 | -0.33 | -0.25 | -0.35 | |
Return on tangible assets | -0.12 | -0.14 | -0.29 | -0.23 | -0.33 | |
Graham Net | 123.03 | 88.68 | 77.55 | 60.57 | 0 | |
Working capital | 2.29B | 1.92B | 1.42B | 1.41B | 1.58B | |
Tangible asset value | 2.16B | 1.84B | 1.29B | 1.32B | 1.47B | |
Net current asset value | 2.12B | 1.77B | 1.21B | 1.23B | 1.39B | |
Invested capital | 0.18 | 0.2 | 0.34 | 0.24 | 0.2 | |
Average receivables | 925.93M | 832.68M | 619.06M | 455.09M | 283.23M | |
Average payables | 272.15M | 56.24M | 73.86M | 48.05M | 0 | |
Average inventory | 17.76M | 16.64M | 8.99M | 9.96M | 8.15M | |
Days sales outstanding | 409.78 | 2.04K | 1.43K | 0 | 0 | |
Days payables outstanding | 33.53 | 143.22 | 61.34K | 0 | 0 | |
Days of inventory on hand | 13.36 | 25.04 | 5.71K | 1.83K | 299.36 | |
Receivables turnover | 0.22 | 0.04 | 0.06 | 0 | 0 | |
Payables turnover | 2.68 | 0.63 | 0 | 0 | 0 | |
Inventory turnover | 6.74 | 3.59 | 0.02 | 0.05 | 0.3 | |
ROE | -0.15 | -0.18 | -0.42 | -0.31 | -0.45 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
4588.T Frequently Asked Questions
What is Oncolys BioPharma Inc. stock symbol ?
Oncolys BioPharma Inc. is a JP stock and trading under the symbol 4588.T
What is Oncolys BioPharma Inc. stock quote today ?
Oncolys BioPharma Inc. stock price is $786 today.
Is Oncolys BioPharma Inc. stock public?
Yes, Oncolys BioPharma Inc. is a publicly traded company.